SHORT VIRTUAL CALL FOR ABSTRACTS - CLOSED
Call for abstracts are now closed for the 17th National Immunisation Conference 2021.
The biennial National Immunisation Conferences are the peak public health conferences in Australia with the prevention and control of vaccine preventable diseases through immunisation as their focus. Run by the Public Health Association of Australia (PHAA), the first conference was held in Canberra in 1987 and over the last 30 years the conferences have grown in stature and influence.
The 2021 National Immunisation Conference will be held as a hybrid conference from Tuesday 29 June to Thursday 1 July 2021 at the Perth Convention & Exhibition Centre, WA.
What is a Hybrid Conference?
A hybrid conference combines a "live" in-person event with a "virtual" online component.
For more information about the hybrid conference, please visit the FAQ's page.
In 2021 the Conference theme will be ‘Immunisation in the COVID pandemic era’’.
Australia has succeeded remarkably in stemming the COVID-19 pandemic through effective strategies to reduce transmission and immunisation will be the most important tool in our weaponry going forward. First Nations Peoples of Australia have demonstrated to us how leadership, consultation, collaboration and effective communication can keep our communities safe during these challenging times. Government, pharma and academia have never previously worked together so hard, to deliver COVID-19 vaccines as a priority for the world’s population, but questions still remain about safety and effectiveness in vulnerable groups such as children and pregnant women.
More than ever, new technologies are being employed and a new world of improved vaccines awaits us. Equity, access and uptake of COVID vaccines and other established immunisation programs will remain the priority for all nations.
This conference will provide a dynamic and engaging forum to discuss all the latest developments in immunisation. 2020 heralds a new and exciting decade of opportunity in preventative health care, of which immunisation is a flagship. The program will include keynote presentations and selected long, short and table top abstract presentations.
To download the Call for Abstracts flyer, please click here.
We warmly encourage you to lock the date in your diaries to join us in Perth at the 17th National Immunisation Conference.
Call for abstracts closed on Sunday 21 March 2021, at 11:59pm AEDT
Virtual Abstract Submission
We welcome submission of abstracts for virtual presentations relevant to one of the Conference themes.
We encourage presentations on Aboriginal and Torres Strait Islander peoples’ health to be presented or co-presented with an Aboriginal and Torres Strait Islander person. We encourage abstracts submitted to note if authors identify as Aboriginal and/or Torres Strait Islander.
Presenters of research focusing on particular Aboriginal and Torres Strait Islander communities should provide an additional paragraph with their abstract outlining whether the relevant community/ies have provided permission to publicise the research findings. An additional 50 word paragraph is permitted in addition to the 300 word maximum.
All abstracts are to be submitted electronically using the online facility on the 17th National Immunisation Conference 2021 website.
Select the Abstract Submission tab and follow the prompts.
It is the submitting author’s responsibility to ensure that the abstract uploaded to the server is the correct version. Online abstract document loading is completed via browsing your selected computer drive. Abstracts submitted for presentation will be published exactly as received and should be checked for spelling and grammar prior to submission.
All presenters must register at the time of confirming their acceptance presentation offer and pay the Conference registration fee.
The program has been designed to provide lively and productive discussions and contributions from all professionals engaged in immunisation from laboratory bench to clinic, from academia and policy making to the service provision coalface.
We invite you to submit abstracts under the following session themes:
COVID virus mutation challenges (Disease aspect)
COVID Clinics – what might work best? (Clinical Practice challenges)
Addressing anticipated hesitancy with COVID vaccination (Acceptance, hesitancy, refusal)
Identifying your COVID vaccine priority group patients (Service delivery)
Ensuring equity and access to COVID vaccine (Equity and access)
Create an environment for knowledge sharing, collaboration and relationship building;
Highlight the challenges, opportunities and activities in immunisation to encourage engagement by delegates to work together to achieve better health outcomes for Australian’s;
Engage professionals from a range of sectors in immunisation;
Provide guidance and insight into capacity building and strengthening of immunisation;
Provide conference delegates with new and innovative ideas that can be applied to local settings and systems to help create and improve health systems for communities – from local to global
The conference will aim to facilitate conversations on improving effectiveness and efficiencies of immunisation through knowledge sharing and relationship building. The program must consider the needs and interests of the immunisation-focussed audience to ensure attraction and participation to the conference.
The target audience will be stakeholders able to effect and/or influence change at the systems and/or practice level including:
Health care professionals – doctors, nurses, allied health, pharmacy, etc working in immunisation and public health;
Vaccine preventable disease control from laboratory bench to clinic;
Commonwealth, state and local government – Ministers, Chief Health officers and staff, and health and social sector department representatives;
Communicable disease epidemiology and laboratory science;
NGO/community and social sector provider and advocacy organisations;
Aboriginal and Torres Strait Islander health workers; and
Organisations in other preventative health fields
Presenters have a total of 10 minutes to present. Abstract submitted must have clear learning objectives and outcomes. All presenters must provide a pre-recorded presentation. Please note, places are limited.
Presenters have a total of 6 minutes’ presentation time using up to 6 power point slides (including title slide). All presenters must provide a pre-recorded presentation. Please note, places are limited.
All intended presentations require the submission of an abstract. All abstracts will be subject to peer review
Refer to the online abstract submission form or manual abstract submission form for requirements
The abstract title should be no longer than 12 words
The abstract should be a maximum of 250 words in simple text paragraphs without images or tables
Maximum of 2 presenters per long oral, maximum of 1 presenter for short oral. All correspondence will be sent to the person whose name and email address is entered with the abstract
Abstract presenters must provide a pre-recorded video of their presentation by the due date to be available on demand for virtual attendees. Guidelines will be provided upon abstract acceptance.
Presenters must be registered to attend the face-to-face or virtual conference in order to present
Presentation offers will be advised in April2021.
For further information contact the PHAA Events Team, on: